Low-Molecular-Weight Heparin Prophylaxis of Deep Vein Thrombosis for Older Patients with Restricted Mobility: Propensity Analyses of Data from Two Multicentre, Cross-Sectional Studies

Author： Labarère José   Sevestre Marie-Antoinette   Belmin Joël  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.26, Iss.3, 2009-01, pp. : 263-271

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of a Low-Molecular-Weight Heparin in Prolonged Prophylaxis Against Deep Vein Thrombosis After Total Hip Replacement

By Detournay B.  

PharmacoEconomics, Vol. 13, Iss. 1 Part 2, 1998-01 ,pp. : 81-89

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Desirudin Compared with a Low Molecular Weight Heparin in the Prevention of Deep Vein Thrombosis after Total Hip Replacement Surgery

By Levin L-å.  

PharmacoEconomics, Vol. 19, Iss. 5, 2001-01 ,pp. : 589-597

Adis International

Access to resources Recommend Favorite

Low molecular weight heparin can prevent progression of isolated calf muscle vein thrombosis

By  

Inpharma, Vol. 1, Iss. 1318, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Pellets for oral administration of low-molecular-weight heparin

By Scala-Bertola Julien   Gajdziok Jan   Rabišková Miloslava   Bonneaux François   Lecompte Thomas   Sapin Anne   Maincent Philippe  

Drug Development and Industrial Pharmacy, Vol. 35, Iss. 12, 2009-12 ,pp. : 1503-1510

Informa Healthcare

Access to resources Recommend Favorite

Low-Molecular-Weight Heparin in Acute Coronary Syndromes

By  

Heart Drug, Vol. 4, Iss. 3, 2004-08 ,pp. : 111-118

Karger

Access to resources Recommend Favorite